Extracellular Protein Quality Control in Tau Pathology
- 1 January 2026
- journal article
- review article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1)
Abstract
Aging is the primary risk factor for neurodegenerative diseases that are marked by the accumulation of misfolded and aggregated proteins, commonly known as proteinopathies. Among these, tauopathies are the disorders characterized by abnormal tau protein aggregation that are particularly significant in Alzheimer's Disease. Tau protein undergoes pathological post-translational modifications that promote its aggregation into neurofibrillary tangles, which disrupt neuronal function and cognitive decline. Tau can also spread between neurons via extracellular pathways in a prion-like manner, accelerating disease progression. Extracellular protein quality control (PQC) mechanisms modulate this process by balancing tau stability and clearance. However, age-related decline in these PQC systems enhances toxic tau assemblies, their extracellular accumulation and widespread dissemination. This review explores tau secretion, propagation, and extracellular protein quality control (PQC) in maintaining tau homeostasis, aiming to identify therapeutic strategies for tauopathies.Keywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology, India (BT/RLF/Re-entry/31/2018)
This publication has 167 references indexed in Scilit:
- Neuron‐Derived Extracellular Vesicles: Emerging Biomarkers and Functional Mediators in Alzheimer's Disease, With Comparative Insights Into Neurodevelopment and AgingDevelopmental Neurobiology, 2025
- Extracellular Vesicle‐Mediated Delivery of 20S Proteasomes Enhances Tau Degradation in Recipient CellsJournal of Extracellular Vesicles, 2025
- Microglia internalize tau monomers and fibrils using distinct receptors but similar mechanismsAlzheimer's & Dementia, 2024
- The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromesAlzheimer's & Dementia, 2024
- The chaperone Clusterin in neurodegeneration−friend or foe?BioEssays, 2022
- Insulin‐degrading enzyme: an ally against metabolic and neurodegenerative diseasesThe Journal of Pathology, 2021
- Tau Secretion2019
- Amyloidogenesis of Tau proteinProtein Science, 2017
- Amyloid-β and TauJAMA Neurology, 2014
- Proteomics, transcriptomics and lipidomics of exosomes and ectosomesProteomics, 2013